Dr. Latt Mansor holds a PhD in Physiology, Anatomy and Genetics from the University of Oxford, where his research focused on the metabolism of the type 2 diabetic heart in hypoxia. He also holds an M.A. (Columbia University) and B.Sc. (Hons) (University of Nottingham) in Biotechnology. He is a world expert in physiology and metabolism, and consults with elite sport, military, clinical and research organizations. Dr. Mansor is the Research Lead at H.V.M.N., overseeing all of the company’s research efforts and collaborations with universities and research institutions. Currently, he is the principal investigator of the $6 million U.S. Special Operations Command (USSOCOM) contract awarded to H.V.M.N by the Department of Defense, with a targeted completion date of October 2022. This project focuses on operator performance in hypoxia (low oxygen environment), which has applications for soldier performance at altitude, in mountains, on fighter jets, and, potentially one day, in space.